Changes in caveolin subtype protein expression in aging rat organs

Molecular and Cellular Endocrinology

Volumn 176, Issue 1-2, 2001, Pages 91-95

  Kawabe, Jun ichi ^a   Grant, B Seth ^a   Yamamoto, Manabu ^a   Schwencke, Carsten ^a   Okumura, Satoshi ^a   Ishikawa, Yoshihiro ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Caveolin; Expression; Ontogenic change; Ras

Indexed keywords

CAVEOLIN; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; RAS PROTEIN;

AGING; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART; IMMUNOBLOTTING; LUNG; MUSCLE; NEWBORN; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TISSUE HOMOGENATE;

AGING; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CAVEOLINS; CENTRIFUGATION, DENSITY GRADIENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LUNG; MUSCLES; MYOCARDIUM; PROTO-ONCOGENE PROTEINS P21(RAS); RATS;

EID: 0035947398     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00472-5     Document Type: Article

References (14)

1. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
2. Couet J., Sargiacomo M., Lisanti M.P. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins: caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272:1997;30429-30438.
3. Engelman J.A., Wykoff C.C., Yasuhara S., Song K.S., Okamoto T., Lisanti M.P. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272:1997;16374-16381.
4. Engelman J., Zhang X., Galbiati F., Lisanti M. Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, cav-2, and cav-3). Cav-1 and cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). FEBS Lett. 429:1998;330-336.
5. Garcia-Cardena G., Oh P., Liu J., Schnitzer J.E., Sessa W.C. Targeting of nirtic oxide synthase to endothelial cell caveolae via palmitoylaiton: implications for nitric oxide signaling. Proc. Natl. Acad. Sci. USA. 93:1996;6448-6453.
6. Li S., Okamoto T., Chun M., Sargiacomo M., Casanova J.E., Hansen S.H., Nishimoto I., Lisanti M.P. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem. 270:1995;15693-15701.
7. Oka N., Yamamoto M., Schwencke C., Kawabe J., Ebina T., Couet J., Lisanti M.P., Ishikawa Y. Caveolin interaction with protein kinase C: Isoenzyme-dependant regulation of kinase activity by the caveolin scaffolding domain peptide. J. Biol. Chem. 272:1997;33416-33421.
8. Okamoto T., Schlegel A., Schere P.E., Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing preassembled signaling complexes at the plasma membrane. J. Biol. Chem. 273:1998;5419-5422.
9. Schlegel A., Volont'e D., Engleman J.A., Galbiati F., Mehta P., Zhang X.L., Scherer P.E., Lisanti M.P. Crowded little caves: structure and funciton of caveolae. Cell Signal. 10:1998;457-463.
10. Schwencke C., Yamamoto M., Okumura S., Geng Y.-J., Ishikawa Y. Colocalization of beta-adrenergic receptors and caveolin within the plasma membrane. J. Cell. Biochem. 75:1999;64-72.
11. Shaul P.W., Anderson R.G. Role of plasmalemmal caveolae in signal transduction. Am. J. Physiol. 275:1998;L843-851.
12. Song K.E., Li S., Okamoto T., Quilliam L.A., Sargiacomo M., Lisanti M. Co-purification and direct interaction of ras with caveolin, an integral membrane protein of caveolae microdomains. J. Biol. Chem. 271:1996;9690-9697.
13. Yamamoto M., Toya Y., Schwencke C., Lisanti M.P., Myers J.M.G., Ishikawa Y. Caveolin is an activator of insulin receptor signaling. J. Biol. Chem. 273:1998;26962-26968.
14. Yamamoto M., Toya Y., Jensen R.A., Ishikawa Y. Caveolin is an inhibitor of platelet-derived growth factor signaling. Exp. Cell Res. 247:1999;380-388.